z-logo
Premium
Thalidomide in POEMS syndrome: Case report
Author(s) -
Sinisalo Marjatta,
Hietaharju Aki,
Sauranen Jukka,
Wirta Ole
Publication year - 2004
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.20051
Subject(s) - poems syndrome , organomegaly , thalidomide , medicine , polyneuropathy , ascites , lenalidomide , gastroenterology , pathology , dermatology , immunology , multiple myeloma
We report a patient with incapacitating POEMS syndrome characterized by serum monoclonal protein, polyneuropathy, organomegaly, endocrinopathy, mesangiocapillary glomerulonephritis, massive ascites formation, and pulmonary hypertension. A dramatic improvement in the clinical condition occurred after administration of thalidomide, a drug with known anti‐angiogenetic, anti‐proliferative, and anti‐cytokine properties. Am. J. Hematol. 76:66–68, 2004. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom